Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4573]

Researchers discover new aspect of gene regulation and possible target for cancer drugs

Researchers discover new aspect of gene regulation and possible target for cancer drugs

Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer

Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple...

Building the foundations for cancer genomic analysis for research and clinical diagnostics

Building the foundations for cancer genomic analysis for research and clinical diagnostics

Drugs prevent heart damage during breast cancer treatment, study shows

Drugs prevent heart damage during breast cancer treatment, study shows

SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer

SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer

Monoclonal antibody increases disease-free survival in breast cancer

Monoclonal antibody increases disease-free survival in breast cancer

Five out of six women at higher risk reject drugs to prevent breast cancer

Five out of six women at higher risk reject drugs to prevent breast cancer

ASH 2015: Blinatumomab data shows benefit in Phase 2 trial in ALL patients with persistent or recurrent minimal residual disease

ASH 2015: Blinatumomab data shows benefit in Phase 2 trial in ALL patients with persistent or recurrent minimal...

ASH 2015: First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival

ASH 2015: First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia...

ASH 2015: Study finds new use for rituximab in acute leukaemia

ASH 2015: Study finds new use for rituximab in acute leukaemia

More from ecancer